Business
Publication of Annual Report 2025 & Notice of AGM
Haleon plc has published its Annual Report and Accounts and Form 20-F for 2025, along with the Notice of its 2026 Annual General Meeting, all of which are available on the company's website. The Annual Report and Form 20-F has also been filed with the US Securities and Exchange Commission. The 2026 AGM will be a virtual meeting held on Wednesday, 29 April 2026, at 3:00 PM BST, with full details and joining instructions provided in the Notice. Disclaimer*
About this update from Haleon Plc
[{"type":"text","content":"\n\n\n \nHaleon plc: Publication of Annual Report and Form 20-F 2025 and Notice of 2026 AGM\n \n13 March 2026: Haleon plc (the \"Company\") announces that the following documents have been published today and are available on its website, www.haleon.com: \n \n- Annual Report and Accounts & Form 20-F 2025 (the 'Annual Report'); and\n- Notice of 2026 Annual General Meeting ('AGM').\n \nIn addition, in accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual, the Annual Report & Form 20-F 2025 will also today be filed with the US Securities and Exchange Commission and will shortly be available at www.sec.gov.\n \nHaleon's AGM will again be a virtual meeting taking place at 3.00pm (BST) on Wednesday, 29 April 2026. The Notice of 2026 AGM is available on the Company's website at https://www.haleon.com/investors/shareholder-information/annual-general-meetings, and includes full details of the business to be conducted and joining instructions.\n \nAmanda Mellor\nCompany Secretary\n \nAbout Haleon\nHaleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world. \n \nFor more information, please visit www.haleon.com. \n \nNotes\nIn compliance with the Disclosure Guidance and Transparency Rules, the Annual Report, as submitted to the National Storage Mechanism, contains regulated information in unedited full text and is available on the Company's website as noted above.\n \nIn compliance with UK Listing Rules 6.4.1(R) and 6.4.3(R) copies of the Annual Report, Notice of AGM, Form of Proxy for the 2026 AGM and Voting Instruction Card have been submitted to the National Storage Mechanism and will shortly be available for inspecti...